Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1995-9-14
pubmed:abstractText
Hepatitis A virus (HAV) is a positive-strand RNA virus with a genome length of approximately 7,480 nucleotides. Although HAV morphogenesis is thought to be similar to that of poliovirus, the prototype picornavirus, the complete characterization of the antigenic structure of this virus remains elusive. All the available evidences, however, support the existence, on HAV virions and empty capsids, of an immunodominant neutralization antigenic site which is conformation dependent and whose structure involves residues of both VP1 and VP3 capsid proteins. This particular feature and the difficulty of obtaining high virus yield in tissue cultures make HAV an ideal target for developing synthetic peptides that simulate the structure of its main antigenic determinant. To this end we utilized, in the present work, the divide-couple-recombine approach to generate a random library composed of millions of different hexapeptides. This vast library was screened with a well-characterized anti-HAV monoclonal antibody. By this strategy we identified a peptide that reacted specifically with monoclonal and polyclonal anti-HAV antibodies and, in mice, induced a specific anti-virus immune response. Furthermore, the peptide could also be used in an enzyme-linked immunosorbent assay for revealing a primary immunoglobulin M immune response in sera of acutely infected human patients. Interestingly, no sequence homology was found between the identified peptide and the HAV capsid proteins VP1 and VP3. Collectively, these data represent an additional important paradigm of a mimotope capable of mimicking an antigenic determinant with unknown tertiary structure.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-1312628, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-1507228, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-1688601, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-1696028, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-1719428, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-1944576, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2413356, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2433464, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2433467, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2443575, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2460866, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2503564, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2552172, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2843673, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2991071, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-2991600, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-3399498, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-3926897, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-4443551, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-5443684, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-6086708, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-6172556, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-6315771, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-6317766, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-7512605, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543581-7678298
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5294-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries.
pubmed:affiliation
Consorzio per le Biotecnologie, Spedali Civili, Brescia, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't